<VariationArchive VariationID="1350152" VariationName="NC_000011.9:g.(?_22242623)_(22277088_?)del" VariationType="Deletion" Accession="VCV001350152" Version="9" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1472975" VariationID="1350152">
      <GeneList>
        <Gene Symbol="ANO5" FullName="anoctamin 5" GeneID="203859" HGNC_ID="HGNC:27337" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22192473" stop="22283357" display_start="22192473" display_stop="22283357" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22214721" stop="22304912" display_start="22214721" display_stop="22304912" Strand="+" />
          </Location>
          <OMIM>608662</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000011.9:g.(?_22242623)_(22277088_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="22242623" innerStop="22277088" display_start="22242623" display_stop="22277088" variantLength="34466" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_22242623)_(22277088_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_22242623)_(22277088_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.9:g.(?_22242623)_(22277088_?)del AND multiple conditions" Accession="RCV002039538" Version="7">
        <ClassifiedConditionList TraitSetID="39863">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22402862</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22980763</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31395899</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39863" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4127287" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_213599.2_11_Deletion (exons 5-13)|MedGen:C1969785;C1833736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002114134" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22402862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22980763</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31395899</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with ANO5-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 5-13 of the ANO5 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ANO5 protein in which other variant(s) (p.Asp81Gly) have been determined to be pathogenic (PMID: 22402862, 22980763, 31395899). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_22242623)_(22277088_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969785" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4127287" TraitType="Disease" MappingType="XRef" MappingValue="C1833736" MappingRef="MedGen">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4127287" TraitType="Disease" MappingType="XRef" MappingValue="C1969785" MappingRef="MedGen">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

